Skip to content
Taxonomy
Augustine Therapeutics Begins New CMT Trial
CMT news out of Belgium: Augustine Therapeutics has officially dosed Read More
CMTA-STAR Partner Applied Therapeutics Presents 24-Month CMT-SORD Data at PNS 2025
The Charcot-Marie-Tooth Association (CMTA) congratulates CMTA Strategy To Accelerate Research Read More
CMTA Presents New Genetic Landscape Analysis at The 2025 Annual Meeting of the Peripheral Nerve Society
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth Read More
CMTA-INC Alliance Announces 2025 Inherited Neuropathies Fellowship Recipient
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth Read More
CMTA Announces New Center of Excellence in Cincinnati
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Read More
Could MRI Help Speed Up CMT1A Research? New Findings from Professor Mary M. Reilly, MBE
A newly published study led by CMTA’s Strategy to Accelerate Read More
CMTA Announces New Center of Excellence in Canada
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Read More
CMTA Invests $210K in Long-Read Sequencing to Accelerate CMT Gene Discovery
Today, the Charcot-Marie-Tooth Association (CMTA) announced a $210,000 investment to Read More
CMT2F Study Achieves Recruitment Goal, Expands to Include Additional Participants
An international team of researchers from the Inherited Neuropathies Consortium Read More
CMTA Announces Its First Center of Excellence in Scotland
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Read More
